Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -196,273 | -152,852 | -99,357 | -52,931 | -199,590 |
| Depreciation Amortization | 10,462 | 7,370 | 4,488 | 2,166 | 6,785 |
| Accounts receivable | -5,019 | -3,200 | -1,719 | -1,419 | -7,862 |
| Accounts payable and accrued liabilities | 3,465 | 1,437 | 903 | 711 | -3,301 |
| Other Working Capital | 1,170 | -2,211 | -1,999 | 602 | -13,308 |
| Other Operating Activity | 25,961 | 19,856 | 12,396 | 5,860 | 26,454 |
| Operating Cash Flow | $-160,234 | $-129,600 | $-85,288 | $-45,011 | $-190,822 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -145 | -26 | -26 | -10 | -206 |
| Purchase Of Investment | -274,577 | -247,911 | -205,773 | -93,882 | -178,489 |
| Sale Of Investment | 221,037 | 162,855 | 99,286 | 47,413 | 257,145 |
| Investing Cash Flow | $-53,685 | $-85,082 | $-106,513 | $-46,479 | $78,450 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 172,083 | 168,115 | 166,875 | 164,829 | 50,696 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 73,609 |
| Financing Cash Flow | $172,083 | $168,115 | $166,875 | $164,829 | $124,305 |
| Exchange Rate Effect | 268 | -15 | -32 | -80 | 19 |
| Beginning Cash Position | 130,689 | 130,689 | 130,689 | 130,689 | 118,737 |
| End Cash Position | 89,121 | 84,107 | 105,731 | 203,948 | 130,689 |
| Net Cash Flow | $-41,568 | $-46,582 | $-24,958 | $73,259 | $11,952 |
| Free Cash Flow | |||||
| Operating Cash Flow | -160,234 | -129,600 | -85,288 | -45,011 | -190,822 |
| Capital Expenditure | -145 | -26 | -26 | -10 | -206 |
| Free Cash Flow | -160,379 | -129,626 | -85,314 | -45,021 | -191,028 |